Leading funders of clinical research around the world say they will require grant holders to register trials in advance and to publish data in full, regardless of whether the results are positive or not

Shortcomings in the framework for clinical trials, little knowledge of intellectual property law and an awkward relationship between scientists and technology transfer offices are holding back science-industry collaboration, but work is in hand to change things

Poland must break down the silos between academics and industry, to build the trust and infrastructures needed to underpin multilateral collaborations, and enable Polish medical researchers to capitalise on pharma’s thirst for external innovation

The EU-funded BASTION project aims to build relationships between science and industry and promote the translation of cancer research into new treatments. But a number of obstacles must be removed before true collaboration can flourish

Europe’s attempt to unify rules on clinical trials in the 2001 Directive is widely acknowledged to be a disaster. After years of debate, the Commission’s proposals for reform are getting a favourable reception, but it is critical the new regulation takes account of emerging technologies